Requisitioning a Resolution at a GSK Annual General Meeting" (60 characters)
undefined
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
a
t
a
G
S
K
A
n
n
u
a
l
G
e
n
e
r
a
l
M
e
e
t
i
n
g
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
There are occasions where shareholders may wish to draw important matters to the attention of
other shareholders by proposing a resolution to be put to an Annual General Meeting (AGM).
This presentation sets out that procedure.
–
The procedure for requisitioning a resolution is governed by English common law and
statute
–
This specifies that, unless a requisition is validly received before the end of the financial
year preceding the meeting, a company’s costs in complying with a requisition are to be
met by requisitionists
–
The funds to cover such costs must be deposited with the company before a requisition
can be actioned
–
GSK has estimated that the cost of complying with a requisition may be as high as
£200,000.
Introduction
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
3
–
At GSK’s AGM in May 2005 the Articles of Association were amended to remove the
requirement for requisitionists to pay a deposit by authorising GSK to meet its own costs
in complying with a valid requisition, provided that the requisition is received by 31
January each year
–
Requisitionists who lodge a requisition after 31 January, but before the UK legal deadline
of 6 weeks prior to the AGM, would, however, be required to pay a deposit and to meet
GSK’s costs of complying with the requisition
–
Requisitionists would, however, be free to include a supplementary resolution to request
that GSK pays its own costs in complying with the requisition
–
Shareholders wishing to requisition a resolution may find the following information helpful,
but should in any event seek their own independent legal advice. A glossary of terms is
set out at the end of this booklet.
Introduction (cont.)
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
4
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
R
e
q
u
i
r
e
m
e
n
t
s
6
Eligibility
8
Procedure
10
Drafting and Submission
13
Supporting Statements
15
Costs
18
S
u
p
p
l
e
m
e
n
t
a
r
y
I
n
f
o
r
m
a
t
i
o
n
K
e
y
d
a
t
e
s
f
o
r
G
S
K
’
s
2
0
1
9
A
G
M
2
1
Contacts
22
Glossary of Terms
23
I
n
d
e
x
5
–
To ensure there is no question of a member or indirect investor with a small shareholding
requisitioning a resolution without sufficient support from other members or indirect
investors, UK law sets out minimum shareholding requirements before a requisition can
be made
–
For a requisition involving only shareholders whose shares are registered directly in their
own name (members), a requisition must be supported by the following in order to be
valid, either:
–
not less than 100 members holding shares on which there has been paid up an average sum per
member of not less than £100; or
–
members representing not less than 5% of the total voting rights of all the members.
Requirements: members
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
6
–
For indirect investors whose shares are held via a nominee or for GSK American
Depository Receipts (ADR) holders, a requisition must be supported by the following in
order to be valid:
–
not less than 100 persons holding shares directly or indirectly on which there has been paid up an
average sum per person of not less than £100.
Requirements: indirect investors
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
7
–
Are you part of a group of 100 or more persons holding £10,000 in nominal value of GSK
Ordinary Shares i.e. 40,000 GSK Ordinary Shares? If the answer is ‘Yes’ then you should
be eligible to requisition a resolution, although certain procedural formalities may be
required
–
If the answer to the above question is ‘No’ then you and the persons with whom you
intend to lodge the requisition might still be eligible to requisition a resolution, if together
you hold at least 5% of the total shareholder voting rights in GSK Ordinary Shares i.e.
approximately 247 million GSK Ordinary Shares
–
If you fulfil neither of the above criteria then you are NOT eligible to requisition a
resolution.
P
L
E
A
S
E
N
O
T
E
:
i
f
y
o
u
r
G
S
K
s
h
a
r
e
s
a
r
e
n
o
t
r
e
g
i
s
t
e
r
e
d
i
n
y
o
u
r
o
w
n
n
a
m
e
o
r
y
o
u
h
o
l
d
G
S
K
A
D
R
s
t
h
e
n
y
o
u
s
h
o
u
l
d
r
e
f
e
r
t
o
p
a
g
e
9
w
h
i
c
h
e
x
p
l
a
i
n
s
h
o
w
y
o
u
s
h
o
u
l
d
p
r
o
c
e
e
d
.
Eligibility: members
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
8
–
Are you part of a group of 100 or more persons holding £10,000 in nominal value of GSK
Ordinary Shares i.e. 40,000 GSK Ordinary Shares or the equivalent thereof in ADRs?
–
If the answer is ‘Yes’ then you should be eligible to requisition a resolution, although
certain procedural formalities may be required. If the answer is ‘No’ then you are NOT
eligible to requisition a resolution.
P
L
E
A
S
E
N
O
T
E
:
i
f
y
o
u
h
o
l
d
G
S
K
A
D
R
s
t
h
e
n
y
o
u
s
h
o
u
l
d
r
e
f
e
r
t
o
p
a
g
e
s
1
0
&
1
1
w
h
i
c
h
e
x
p
l
a
i
n
s
h
o
w
y
o
u
s
h
o
u
l
d
p
r
o
c
e
e
d
.
I
f
y
o
u
r
G
S
K
s
h
a
r
e
s
a
r
e
n
o
t
r
e
g
i
s
t
e
r
e
d
i
n
y
o
u
r
o
w
n
n
a
m
e
t
h
e
n
y
o
u
s
h
o
u
l
d
r
e
f
e
r
t
o
p
a
g
e
1
2
.
Eligibility: indirect investors
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
9
–
ADR holders who hold their ADRs directly with GSK’s ADR Depositary, BNYM, may
submit a requisition through BNYM provided that the requisition is:
–
submitted by at least 100 persons with an average of £100 of paid up share capital each and
authenticated by all the persons making it; and
–
accompanied by a statement from BNYM or the underlying ADR holder(s) making the request
setting out the basis on which ADRs are being held by them/for them.
P
L
E
A
S
E
N
O
T
E
:
a
n
y
c
o
s
t
s
a
s
s
o
c
i
a
t
e
d
w
i
t
h
i
m
p
l
e
m
e
n
t
i
n
g
t
h
e
s
e
a
r
r
a
n
g
e
m
e
n
t
s
w
i
l
l
n
o
t
b
e
m
e
t
b
y
G
S
K
.
Procedure: ADR holders with BNY Mellon
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
10
–
ADR holders who do not hold their ADRs via BNYM may submit a requisition provided
that it is:
–
submitted by at least 100 persons with an average of £100 of paid up capital each and
authenticated by all the persons making it; and
–
accompanied by a statement from the relevant broker, nominee or other institution through which
the ADRs are held, or the underlying ADR holder(s) making the request, setting out the basis on
which ADRs are being held by them/for them.
P
L
E
A
S
E
N
O
T
E
:
a
n
y
c
o
s
t
s
a
s
s
o
c
i
a
t
e
d
w
i
t
h
i
m
p
l
e
m
e
n
t
i
n
g
t
h
e
s
e
a
r
r
a
n
g
e
m
e
n
t
s
w
i
l
l
n
o
t
b
e
m
e
t
b
y
G
S
K
.
Procedure: ADR holders via a broker, nominee or institution
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
11
–
Indirect investors holding GSK Ordinary shares via a nominee may submit a requisition
provided that the requisition is:
–
submitted by at least 100 persons with an average of £100 of paid up share capital each and
authenticated by all the persons making it; and
–
accompanied by a statement from the nominee or underlying shareholder(s) making the request
setting out the basis on which the GSK shares are being held by them/for them. More details about
this statement are set out on pages 15 to 17.
P
L
E
A
S
E
N
O
T
E
:
a
n
y
c
o
s
t
s
a
s
s
o
c
i
a
t
e
d
w
i
t
h
i
m
p
l
e
m
e
n
t
i
n
g
t
h
e
s
e
a
r
r
a
n
g
e
m
e
n
t
s
w
i
l
l
n
o
t
b
e
m
e
t
b
y
G
S
K
.
Procedure: Ordinary Shareholders via a nominee
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
12
–
Requisitionists are strongly recommended to seek independent legal advice on the
drafting of their requisition
–
Please note that GSK will not meet the requisitionists’ legal or other costs in preparing a
requisition.
Drafting and submission
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
13
–
Points to note:
–
The requisition should be in English and in a readable form
–
It may be in hard copy or electronic form
–
The resolution being proposed should be capable of being put to a general meeting and should not
be defamatory, frivolous or vexatious
–
Where it is being submitted by members the requisition should be signed by all the persons making
it, specifying for each member their full name, registered address, account number and the number
of GSK Ordinary shares they hold
–
Where a requisition is being submitted by an ADR holder(s) the requisition should be accompanied
by a statement setting out the name and address of the registered holder(s), the number of
shares/ADRs held and the basis on which the shares/ADRs are being held.
Drafting and submission (cont.)
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
14
–
Where a requisition for a resolution is being supported by indirect investors as part of the
100 persons requirement (as set out on pages 9 and 12) the requisition must be signed
by all the persons making it and be accompanied by a statement for each indirect
investor which includes the following:
–
the name and address of the registered member who holds the shares on their behalf;
–
confirmation that the member is holding those shares on their behalf in the course of business;
–
details of the number of shares held on their behalf and the total amount paid up on those shares;
–
confirmation that those shares are not held by the member on behalf of anyone else or, if they are,
that such other persons are not involved in the requisition;
–
confirmation that at least some of the shares confer voting rights; and
–
confirmation that they have the right to instruct the member on how to exercise those voting rights.
Supporting Statements
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
15
–
If any of the 100 persons is a member, the requisition must also be accompanied by a
statement for each such member specifying that they hold shares otherwise than on
behalf of another person or that they hold shares on behalf of one or more other persons
but those persons are not involved in the requisition
–
This statement should also specify for each member the total amount paid up on the
shares held as mentioned in the previous sentence.
–
GSK may also require that the supporting statements are accompanied with such
evidence of the above matters which it may reasonably require.
Supporting Statements (cont.)
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
16
–
These requirements also apply where indirect investors support a 100 persons requisition
for the circulation of an explanatory statement (see immediately below)
–
The proposed resolution may be accompanied by an explanatory statement of not more than 1,000
(one thousand) words, which should also be signed by each of the requisitionists
–
The resolution, and where supplied an accompanying statement, will be issued on behalf of the
requisitionists without giving their names
–
A specific request should be made for each requisitionist’s name to be published
–
When complying with such a request, space constraints may require that a full list of these names
be set out in an appendix to the Notice of Meeting.
Supporting Statements (cont.)
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
17
–
UK law specifies that the burden of a company’s costs in complying with a requisition falls
on the requisitionists unless a requisition is validly received before the end of the financial
year preceding the AGM (31 December).
–
GSK has extended this deadline to 31 January. Therefore, unless a requisition is validly received
by this date, the requisitionists are required by law to deposit with GSK a sum reasonably sufficient
to meet GSK’s expenses in giving effect to a requisition
–
It is estimated that the cost of requisitioning a resolution could be as high as £200,000. The actual
costs of processing a requisition and accordingly the deposit required would be established at the
time of receipt of a requisition
–
Requisitionists are entitled to include as part of their requisition a supplementary resolution for
shareholders to authorise GSK to meet the costs of complying with the requisition. GSK would
reimburse the amount deposited if the supplementary resolution is approved.
Costs
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
18
–
GSK will meet its costs in complying with a requisition provided that a valid request is
received by 31 January
–
Requisitionists who lodge their requisition after that date will be required to deposit with
the company sufficient funds to cover the costs in complying with the requisition and
should consider including a supplementary resolution seeking approval for GSK to meet
its own costs in complying with the requisition
–
If any supplementary resolution is passed allowing GSK to meet its own costs in
complying with the requisition, GSK will refund the deposit within 10 working days of the
AGM.
–
P
l
e
a
s
e
n
o
t
e
t
h
a
t
r
e
q
u
i
s
i
t
i
o
n
i
s
t
s
w
i
l
l
i
n
a
n
y
e
v
e
n
t
h
a
v
e
t
o
m
e
e
t
t
h
e
i
r
o
w
n
c
o
s
t
s
i
n
p
u
t
t
i
n
g
f
o
r
w
a
r
d
t
h
e
r
e
q
u
i
s
i
t
i
o
n
.
P
L
E
A
S
E
N
O
T
E
:
r
e
q
u
i
s
i
t
i
o
n
i
s
t
s
m
a
y
s
u
b
m
i
t
a
s
u
p
p
l
e
m
e
n
t
a
r
y
r
e
s
o
l
u
t
i
o
n
t
o
s
e
e
k
a
p
p
r
o
v
a
l
f
o
r
G
S
K
t
o
m
e
e
t
i
t
s
c
o
s
t
s
i
n
c
o
m
p
l
y
i
n
g
w
i
t
h
t
h
e
r
e
q
u
i
s
i
t
i
o
n
.
Costs (cont.)
R
e
q
u
i
s
i
t
i
o
n
i
n
g
a
r
e
s
o
l
u
t
i
o
n
19
Key dates, contacts and glossary of terms
S
u
p
p
l
e
m
e
n
t
a
r
y
I
n
f
o
r
m
a
t
i
o
n
21
S
u
p
p
l
e
m
e
n
t
a
r
y
I
n
f
o
r
m
a
t
i
o
n
Key dates for GSK’s 2019 AGM
P
L
E
A
S
E
N
O
T
E
:
T
h
e
s
e
d
a
t
e
s
m
a
y
b
e
s
u
b
j
e
c
t
t
o
c
h
a
n
g
e
w
h
i
c
h
w
i
l
l
b
e
p
o
s
t
e
d
o
n
t
h
e
w
e
b
s
i
t
e
22
S
u
p
p
l
e
m
e
n
t
a
r
y
I
n
f
o
r
m
a
t
i
o
n
Contacts
If you wish to discuss any of these requirements then please contact:
V
i
c
t
o
r
i
a
W
h
y
t
e
C
o
m
p
a
n
y
S
e
c
r
e
t
a
r
y
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex TW8 9GS
Tel: +44 (0)20 8047 5000
23
S
u
p
p
l
e
m
e
n
t
a
r
y
I
n
f
o
r
m
a
t
i
o
n
Glossary of Terms
−
R
e
q
u
i
s
i
t
i
o
n
:
a
f
o
r
m
a
l
r
e
q
u
e
s
t
t
o
a
c
o
m
p
a
n
y
f
r
o
m
o
n
e
o
r
m
o
r
e
o
f
i
t
s
m
e
m
b
e
r
s
o
r
i
n
d
i
r
e
c
t
i
n
v
e
s
t
o
r
s
t
o
p
u
t
a
r
e
s
o
l
u
t
i
o
n
t
o
a
n
A
G
M
.
−
R
e
s
o
l
u
t
i
o
n
:
a
p
r
o
p
o
s
a
l
f
o
r
m
e
m
b
e
r
s
o
f
a
c
o
m
p
a
n
y
t
o
c
o
n
s
i
d
e
r
a
n
d
d
e
c
i
d
e
u
p
o
n
.
−
A
D
R
:
a
n
A
m
e
r
i
c
a
n
D
e
p
o
s
i
t
a
r
y
R
e
c
e
i
p
t
r
e
p
r
e
s
e
n
t
i
n
g
t
w
o
G
S
K
O
r
d
i
n
a
r
y
s
h
a
r
e
s
a
l
s
o
r
e
f
e
r
r
e
d
t
o
a
s
a
n
A
m
e
r
i
c
a
n
D
e
p
o
s
i
t
a
r
y
S
h
a
r
e
.
−
B
N
Y
M
:
B
N
Y
M
e
l
l
o
n
D
e
p
o
s
i
t
a
r
y
R
e
c
e
i
p
t
s
,
G
S
K
’
s
d
e
p
o
s
i
t
a
r
y
b
a
n
k
w
h
i
c
h
h
o
l
d
s
A
D
R
s
o
n
b
e
h
a
l
f
o
f
i
n
v
e
s
t
o
r
s
.
−
M
e
m
b
e
r
:
a
s
h
a
r
e
h
o
l
d
e
r
w
h
o
s
e
n
a
m
e
a
p
p
e
a
r
s
o
n
t
h
e
R
e
g
i
s
t
e
r
o
f
M
e
m
b
e
r
s
,
m
a
i
n
t
a
i
n
e
d
b
y
G
S
K
’
s
R
e
g
i
s
t
r
a
r
,
E
q
u
i
n
i
t
i
.
−
I
n
d
i
r
e
c
t
i
n
v
e
s
t
o
r
:
a
p
e
r
s
o
n
o
n
w
h
o
s
e
b
e
h
a
l
f
a
m
e
m
b
e
r
h
o
l
d
s
G
S
K
O
r
d
i
n
a
r
y
S
h
a
r
e
s
.
Procedure for requisitioning a resolution at GlaxoSmithKline's Annual General Meeting (AGM) including requirements, eligibility, costs, key dates, and contacts. Shareholders can propose resolutions to address important matters to other shareholders. GSK has specific rules and deadlines for requisitions, as outlined in its Articles of Association. (Name references minimized) (303 characters)
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Requisitioning a resolution at a GSK Annual General Meeting
Requisitioning a resolution There are occasions where shareholders may wish to draw important matters to the attention of other shareholders by proposing a resolution to be put to an Annual General Meeting (AGM). This presentation sets out that procedure.
Requisitioning a resolution Introduction The procedure for requisitioning a resolution is governed by English common law and statute This specifies that, unless a requisition is validly received before the end of the financial year preceding the meeting, a company s costs in complying with a requisition are to be met by requisitionists The funds to cover such costs must be deposited with the company before a requisition can be actioned GSK has estimated that the cost of complying with a requisition may be as high as 200,000. 3
Requisitioning a resolution Introduction (cont.) At GSK s AGM in May 2005 the Articles of Association were amended to remove the requirement for requisitionists to pay a deposit by authorising GSK to meet its own costs in complying with a valid requisition, provided that the requisition is received by 31 January each year Requisitionists who lodge a requisition after 31 January, but before the UK legal deadline of 6 weeks prior to the AGM, would, however, be required to pay a deposit and to meet GSK s costs of complying with the requisition Requisitionists would, however, be free to include a supplementary resolution to request that GSK pays its own costs in complying with the requisition Shareholders wishing to requisition a resolution may find the following information helpful, but should in any event seek their own independent legal advice. A glossary of terms is set out at the end of this booklet. 4
Index Requisitioning a resolution Requirements Eligibility Procedure Drafting and Submission Supporting Statements Costs 6 8 10 13 15 18 Supplementary Information Key dates for GSK s 2019 AGM Contacts Glossary of Terms 21 22 23 5
Requisitioning a resolution Requirements: members To ensure there is no question of a member or indirect investor with a small shareholding requisitioning a resolution without sufficient support from other members or indirect investors, UK law sets out minimum shareholding requirements before a requisition can be made For a requisition involving only shareholders whose shares are registered directly in their own name (members), a requisition must be supported by the following in order to be valid, either: not less than 100 members holding shares on which there has been paid up an average sum per member of not less than 100; or members representing not less than 5% of the total voting rights of all the members. 6
Requisitioning a resolution Requirements: indirect investors For indirect investors whose shares are held via a nominee or for GSK American Depository Receipts (ADR) holders, a requisition must be supported by the following in order to be valid: not less than 100 persons holding shares directly or indirectly on which there has been paid up an average sum per person of not less than 100. 7
Requisitioning a resolution Eligibility: members Are you part of a group of 100 or more persons holding 10,000 in nominal value of GSK Ordinary Shares i.e. 40,000 GSK Ordinary Shares? If the answer is Yes then you should be eligible to requisition a resolution, although certain procedural formalities may be required If the answer to the above question is No then you and the persons with whom you intend to lodge the requisition might still be eligible to requisition a resolution, if together you hold at least 5% of the total shareholder voting rights in GSK Ordinary Shares i.e. approximately 247 million GSK Ordinary Shares If you fulfil neither of the above criteria then you are NOT eligible to requisition a resolution. PLEASE NOTE: if your GSK shares are not registered in your own name or you hold GSK ADRs then you should refer to page 9 which explains how you should proceed. 8
Requisitioning a resolution Eligibility: indirect investors Are you part of a group of 100 or more persons holding 10,000 in nominal value of GSK Ordinary Shares i.e. 40,000 GSK Ordinary Shares or the equivalent thereof in ADRs? If the answer is Yes then you should be eligible to requisition a resolution, although certain procedural formalities may be required. If the answer is No then you are NOT eligible to requisition a resolution. PLEASE NOTE: if you hold GSK ADRs then you should refer to pages 10 & 11 which explains how you should proceed. If your GSK shares are not registered in your own name then you should refer to page 12. 9
Requisitioning a resolution Procedure: ADR holders with BNY Mellon ADR holders who hold their ADRs directly with GSK s ADR Depositary, BNYM, may submit a requisition through BNYM provided that the requisition is: submitted by at least 100 persons with an average of 100 of paid up share capital each and authenticated by all the persons making it; and accompanied by a statement from BNYM or the underlying ADR holder(s) making the request setting out the basis on which ADRs are being held by them/for them. PLEASE NOTE: any costs associated with implementing these arrangements will not be met by GSK. 10
Requisitioning a resolution Procedure: ADR holders via a broker, nominee or institution ADR holders who do not hold their ADRs via BNYM may submit a requisition provided that it is: submitted by at least 100 persons with an average of 100 of paid up capital each and authenticated by all the persons making it; and accompanied by a statement from the relevant broker, nominee or other institution through which the ADRs are held, or the underlying ADR holder(s) making the request, setting out the basis on which ADRs are being held by them/for them. PLEASE NOTE: any costs associated with implementing these arrangements will not be met by GSK. 11
Requisitioning a resolution Procedure: Ordinary Shareholders via a nominee Indirect investors holding GSK Ordinary shares via a nominee may submit a requisition provided that the requisition is: submitted by at least 100 persons with an average of 100 of paid up share capital each and authenticated by all the persons making it; and accompanied by a statement from the nominee or underlying shareholder(s) making the request setting out the basis on which the GSK shares are being held by them/for them. More details about this statement are set out on pages 15 to 17. PLEASE NOTE: any costs associated with implementing these arrangements will not be met by GSK. 12
Requisitioning a resolution Drafting and submission Requisitionists are strongly recommended to seek independent legal advice on the drafting of their requisition Please note that GSK will not meet the requisitionists legal or other costs in preparing a requisition. 13
Requisitioning a resolution Drafting and submission (cont.) Points to note: The requisition should be in English and in a readable form It may be in hard copy or electronic form The resolution being proposed should be capable of being put to a general meeting and should not be defamatory, frivolous or vexatious Where it is being submitted by members the requisition should be signed by all the persons making it, specifying for each member their full name, registered address, account number and the number of GSK Ordinary shares they hold Where a requisition is being submitted by an ADR holder(s) the requisition should be accompanied by a statement setting out the name and address of the registered holder(s), the number of shares/ADRs held and the basis on which the shares/ADRs are being held. 14
Requisitioning a resolution Supporting Statements Where a requisition for a resolution is being supported by indirect investors as part of the 100 persons requirement (as set out on pages 9 and 12) the requisition must be signed by all the persons making it and be accompanied by a statement for each indirect investor which includes the following: the name and address of the registered member who holds the shares on their behalf; confirmation that the member is holding those shares on their behalf in the course of business; details of the number of shares held on their behalf and the total amount paid up on those shares; confirmation that those shares are not held by the member on behalf of anyone else or, if they are, that such other persons are not involved in the requisition; confirmation that at least some of the shares confer voting rights; and confirmation that they have the right to instruct the member on how to exercise those voting rights. 15
Requisitioning a resolution Supporting Statements (cont.) If any of the 100 persons is a member, the requisition must also be accompanied by a statement for each such member specifying that they hold shares otherwise than on behalf of another person or that they hold shares on behalf of one or more other persons but those persons are not involved in the requisition This statement should also specify for each member the total amount paid up on the shares held as mentioned in the previous sentence. GSK may also require that the supporting statements are accompanied with such evidence of the above matters which it may reasonably require. 16
Requisitioning a resolution Supporting Statements (cont.) These requirements also apply where indirect investors support a 100 persons requisition for the circulation of an explanatory statement (see immediately below) The proposed resolution may be accompanied by an explanatory statement of not more than 1,000 (one thousand) words, which should also be signed by each of the requisitionists The resolution, and where supplied an accompanying statement, will be issued on behalf of the requisitionists without giving their names A specific request should be made for each requisitionist s name to be published When complying with such a request, space constraints may require that a full list of these names be set out in an appendix to the Notice of Meeting. 17
Requisitioning a resolution Costs UK law specifies that the burden of a company s costs in complying with a requisition falls on the requisitionists unless a requisition is validly received before the end of the financial year preceding the AGM (31 December). GSK has extended this deadline to 31 January. Therefore, unless a requisition is validly received by this date, the requisitionists are required by law to deposit with GSK a sum reasonably sufficient to meet GSK s expenses in giving effect to a requisition It is estimated that the cost of requisitioning a resolution could be as high as 200,000. The actual costs of processing a requisition and accordingly the deposit required would be established at the time of receipt of a requisition Requisitionists are entitled to include as part of their requisition a supplementary resolution for shareholders to authorise GSK to meet the costs of complying with the requisition. GSK would reimburse the amount deposited if the supplementary resolution is approved. 18
Requisitioning a resolution Costs (cont.) GSK will meet its costs in complying with a requisition provided that a valid request is received by 31 January Requisitionists who lodge their requisition after that date will be required to deposit with the company sufficient funds to cover the costs in complying with the requisition and should consider including a supplementary resolution seeking approval for GSK to meet its own costs in complying with the requisition If any supplementary resolution is passed allowing GSK to meet its own costs in complying with the requisition, GSK will refund the deposit within 10 working days of the AGM. Please note that requisitionists will in any event have to meet their own costs in putting forward the requisition. PLEASE NOTE: requisitionists may submit a supplementary resolution to seek approval for GSK to meet its costs in complying with the requisition. 19
Supplementary Information Key dates, contacts and glossary of terms
Supplementary Information Key dates for GSK s 2019 AGM Action Date Recommended submission date for member(s)/ADR holders wishing to requisition a resolution 31 January Annual Report and AGM materials to be issued March 2019 UK legal deadline for member(s)/ADR holders wishing to requisition a resolution TBC 2019 Annual General Meeting TBC PLEASE NOTE: These dates may be subject to change which will be posted on the website 21
Supplementary Information Contacts If you wish to discuss any of these requirements then please contact: Victoria Whyte Company Secretary GlaxoSmithKline plc 980 Great West Road Brentford Middlesex TW8 9GS Tel: +44 (0)20 8047 5000 22
Supplementary Information Glossary of Terms Requisition: a formal request to a company from one or more of its members or indirect investors to put a resolution to an AGM. Resolution: a proposal for members of a company to consider and decide upon. ADR: an American Depositary Receipt representing two GSK Ordinary shares also referred to as an American Depositary Share. BNYM: BNY Mellon Depositary Receipts, GSK s depositary bank which holds ADRs on behalf of investors. Member: a shareholder whose name appears on the Register of Members, maintained by GSK s Registrar, Equiniti. Indirect investor: a person on whose behalf a member holds GSK Ordinary Shares. 23
